<DOC>
	<DOC>NCT01673451</DOC>
	<brief_summary>This is a single-center, randomized, double-blind, placebo-controlled, sequential, multiple-dose study. The study will be conducted in two parts: Part A (6 cohorts of healthy adults receiving evening dosing) and Part B (one cohort of elderly adults receiving evening dosing).</brief_summary>
	<brief_title>2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects</brief_title>
	<detailed_description />
	<criteria>Included: Healthy males or females, ages 18 to 55 years (Part A) or 65 to 80 years (Part B) Who report typical time in bed 7.5 to 9 hours Who report typical bedtime 22:00 24:00 and typical wake time 06:00 08:00 Who report typical sleep latency of &lt;= 30 minutes All females must be of nonchildbearing potential, or subjects who have been sterilized surgically or who are otherwise proven sterile. Females must have a negative serum betahuman chorionic gonadotropin (BetahCG) test result at Screening and a negative urine pregnancy test at Baseline. Body mass index BMI &gt; 18 and 32 kg/m2 at Screening Excluded: Performed shift work within 2 weeks prior to Screening Had taken a flight across three or more time zones in the 7 days prior to Screening Female subjects who are nursing With a history of gastrointestinal surgery (hepatectomy, nephrectomy, digestive organ resection, etc.) that may affect PK profile of E2006 With a known history of clinically significant drug or food allergies or presently experiencing significant seasonal allergy Hypersensitivity to the study drug or any of the excipients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>insomnia</keyword>
</DOC>